Author

Antonio Filareto

Principle Scientist, Regenerative Medicine - Boehringer Ingelheim Pharmaceuticals, Inc. - Cited by 916 - Stem cell - gene therapy - regenerative medicine

Biography

I am Antonio Filareto, belonging toLillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN, interested in the field  of Utrophin.                                     
Title
Cited by
Year
An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
A Filareto, S Parker, R Darabi, L Borges, M Iacovino, T Schaaf, ...Nature communications 4 (1), 1549, 2013201
155
2013
In Vivo and In Vitro Studies Support That a New Splicing Isoform of OLR1 Gene Is Protective Against Acute Myocardial Infarction
R Mango, S Biocca, F del Vecchio, F Clementi, F Sangiuolo, F Amati, ...Circulation Research 97 (2), 152-158, 2005200
132
2005
Assessment of the Myogenic Stem Cell Compartment Following Transplantation of Pax3/Pax7-Induced Embryonic Stem Cell-Derived Progenitors
R Darabi, FNC Santos, A Filareto, W Pan, R Koene, MA Rudnicki, M Kyba, ...Stem cells 29 (5), 777-790, 2011201
132
2011
Compound Heterozygosity for Mutations in LMNA in a Patient with a Myopathic and Lipodystrophic Mandibuloacral Dysplasia Type A Phenotype
F Lombardi, F Gullotta, M Columbaro, A Filareto, M D’Adamo, A Vielle, ...The Journal of Clinical Endocrinology & Metabolism 92 (11), 4467-4471, 2007200
63
2007
Stem cell therapy for muscular dystrophies
S Biressi, A Filareto, TA RandoThe Journal of Clinical Investigation 130 (11), 5652-5664, 2020202
53
2020
Membrane-stabilizing copolymers confer marked protection to dystrophic skeletal muscle in vivo
EM Houang, KJ Haman, A Filareto, RC Perlingeiro, FS Bates, DA Lowe, ...Molecular Therapy-Methods & Clinical Development 2, 2015201
50
2015
Identification of multipotent cytotrophoblast cells from human first trimester chorionic villi
P Spitalieri, G Cortese, A Pietropolli, A Filareto, S Dolci, FG Klinger, ...Cloning and stem cells 11 (4), 535-556, 2009200
50
2009
Skeletal muscle stem cells from PSC-derived teratomas have functional regenerative capacity
SSK Chan, RW Arpke, A Filareto, N Xie, MP Pappas, JS Penaloza, ...Cell Stem Cell 23 (1), 74-85. e6, 2018201
43
2018
IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy
M Murdocca, A Malgieri, A Luchetti, L Saieva, G Dobrowolny, ...Molecular medicine 18, 1076-1085, 2012201
41
2012
Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy
RCR PerlingeiroJournal of Stem Cell Research & Therapy, 2012201
38
2012
In vitro restoration of functional SMN protein in human trophoblast cells affected by spinal muscular atrophy by small fragment homologous replacement
F Sangiuolo, A Filareto, P Spitalieri, ML Scaldaferri, R Mango, E Bruscia, ...Human gene therapy 16 (7), 869-880, 2005200
37
2005
Cftr gene targeting in mouse embryonic stem cells mediated by Small Fragment Homologous Replacement (SFHR)
F Sangiuolo, ML Scaldaferri, A Filareto, P Spitalieri, L Guerra, M Favia, ...Frontiers in bioscience: a journal and virtual library 13, 2989, 2008200
30
2008
Deletion of SA β‐Gal+ cells using senolytics improves muscle regeneration in old mice
CM Dungan, KA Murach, CJ Zdunek, ZJ Tang, GL VonLehmden, ...Aging Cell 21 (1), e13528, 2022202
19
2022
Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy
PP Ho, LJ Lahey, F Mourkioti, PE Kraft, A Filareto, M Brandt, ...Proceedings of the National Academy of Sciences 115 (39), E92-E9191, 202
18
2018
Pax3-induced expansion enables the genetic correction of dystrophic satellite cells
A Filareto, F Rinaldi, RW Arpke, R Darabi, JJ Belanto, EA Toso, AZ Miller, ...Skeletal Muscle 5, 1-11, 2015201
18
2015
Small fragment homologous replacement: evaluation of factors influencing modification efficiency in an eukaryotic assay system
A Luchetti, A Filareto, M Sanchez, G Ferraguti, M Lucarelli, G Novelli, ...Plos one 7 (2), e30851, 2012201
6
2012
Monitoring disease activity noninvasively in the mdx model of Duchenne muscular dystrophy
A Filareto, K Maguire-Nguyen, Q Gan, G Aldanondo, L Machado, ...Proceedings of the National Academy of Sciences 115 (30), 7741-774, 2018201
6
2018
Prenatal diagnosis of spinal muscular atrophy with respiratory distress (SMARD1) in a twin pregnancy
F Sangiuolo, A Filareto, E Giardina, AM Nardone, G Pilu, A Pietropolli, ...Prenatal Diagnosis: Published in Affiliation With the International Society …, 2004200
5
2004
Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy
BL Lin, JY Shin, WPD Jeffreys, N Wang, CA Lukban, MC Moorer, ...JCI insight 7 (19), 2022202
4
2022
312. gene correction of LGMD2A patient-specific iPS cells for targeted autologous cell therapy
12. gene correction of LGMD2A patient-specific iPS cells for targeted autologous cell therapyS Selvaraj, A Filareto, J Kiley, D Voytas, M Kyba, R PerlingeiroMolecular Therapy 24, S125-S126, 2016201
3
2016

Referred From: https://scholar.google.com/citations?user=a6M7NFEAAAAJ&hl=en

Cited by
Citations 916
h-index 15
i10-index 15
Recommended Journals
Open Access Journals